Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
225 hedge funds and large institutions have $2.41B invested in Exact Sciences in 2017 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 76 increasing their positions, 72 reducing their positions, and 32 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 2 → 8 (+6)
84% more capital invested
Capital invested by funds: $1.3B → $2.41B (+$1.1B)
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
30% more call options, than puts
Call options by funds: $56.7M | Put options by funds: $43.7M
2.1% more ownership
Funds ownership: 90.03% → 92.14% (+2.1%)
6% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 72
1% more funds holding
Funds holding: 223 → 225 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$135M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$62.5M |
| 3 |
JP Morgan Chase
New York
|
+$48.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$46.5M |
| 5 |
Millennium Management
New York
|
+$44.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$66.6M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$46.2M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$35.5M |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.9M |
| 5 |
D.E. Shaw & Co
New York
|
-$15.6M |
EXAS Hedge Fund Activity: Q1 2017 in Review
225 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2017, worth a combined $2.41B — up 84% from $1.3B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new EXAS positions and 32 closed out — a net gain of 11 holders — while 76 added to existing stakes and 72 trimmed.
The largest buyer was BlackRock, adding an estimated $135M. The largest seller was Citigroup, cutting an estimated $66.6M.
- 225 institutional investors held Exact Sciences (EXAS) as of Q1 2017, up from 223 in Q4 2016.
- Funds reported $2.41B of Exact Sciences stock for Q1 2017, up 84% quarter-over-quarter.
- 43 funds opened new Exact Sciences positions in Q1 2017 and 32 closed out, a net change of +11 holders.
- The largest Exact Sciences buyer in Q1 2017 was BlackRock, an estimated $135M added.
- The largest Exact Sciences seller in Q1 2017 was Citigroup, an estimated $66.6M sold.
Based on aggregated 13F filings for Q1 2017.